Cargando…
CD98 heavy chain as a prognostic biomarker and target for cancer treatment
The SLC3A2 gene encodes for a cell-surface transmembrane protein CD98hc (4F2). CD98hc serves as a chaperone for LAT1 (SLC7A5), LAT2 (SLC7A8), y(+)LAT1 (SLC7A7), y(+)LAT2 (SLC7A6), xCT (SLC7A11) and Asc1 (SLC7A10) providing their recruitment to the plasma membrane. Together with the light subunits, i...
Autores principales: | Xia, Pu, Dubrovska, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562705/ https://www.ncbi.nlm.nih.gov/pubmed/37823053 http://dx.doi.org/10.3389/fonc.2023.1251100 |
Ejemplares similares
-
Metabolic Targeting of Cancer Stem Cells
por: Mukha, Anna, et al.
Publicado: (2020) -
CD98 Heavy Chain Is a Potent Positive Regulator of CD4(+) T Cell Proliferation and Interferon-γ Production In Vivo
por: Kurihara, Takeshi, et al.
Publicado: (2015) -
A Unique Human Immunoglobulin Heavy Chain Variable Domain-Only CD33 CAR for the Treatment of Acute Myeloid Leukemia
por: Schneider, Dina, et al.
Publicado: (2018) -
Tumor-Associated CD68(+), CD163(+), and MARCO(+) Macrophages as Prognostic Biomarkers in Patients With Treatment-Naïve Gastroesophageal Adenocarcinoma
por: Jeremiasen, Martin, et al.
Publicado: (2020) -
Novel Therapeutic Strategies for Ovarian Cancer Stem Cells
por: Terraneo, Nastassja, et al.
Publicado: (2020)